The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

Journal of the American College of Cardiology

Volumn 49, Issue 23, 2007, Pages 2249-2255

  Fox, Keith A A ^a   Antman, Elliott M ^b   Montalescot, Gilles ^c   Agewall, Stefan ^d   SomaRaju, Bhupathi ^e   Verheugt, Freek W A ^f   Lopez Sendon, Jose ^g   Hod, Hanoch ^h   Murphy, Sabina A ^b   Braunwald, Eugene ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e CARE HOSPITAL   (India)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^h SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HEPARIN; STATINE DERIVATIVE; STREPTOKINASE;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; FEMALE; HEART INFARCTION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CREATININE; DOUBLE-BLIND METHOD; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RENAL INSUFFICIENCY; THROMBOLYTIC THERAPY;

EID: 34249901305     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.12.049     Document Type: Article

References (26)

1. Culleton B.F., Larson M.G., Evans J.C., et al. Prevalence and correlates of elevated serum creatinine levels: the Framingham heart study. Arch Intern Med 159 (1999) 1785-1790
2. Landray M.J., Thambyrajah J., McGlynn F.J., et al. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 38 (2001) 537-546
3. Culleton B.F., Larson M.G., Wilson P.W., et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56 (1999) 2214-2219
4. Cerne D., Kaplan-Pavlovcic S., Kranjec I., et al. Mildly elevated serum creatinine concentration correlates with the extent of coronary atherosclerosis. Ren Fail 22 (2000) 799-808
5. Fried L.F., Shlipak M.G., Crump C., et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41 (2003) 1364-1372
6. Santopinto J.J., Fox K.A., Goldberg R.J., et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart 89 (2003) 1003-1008
7. Shlipak M.G., Heidenreich P.A., Noguchi H., et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137 (2002) 555-562
8. Pahor M., Shorr R.I., Somes G.W., et al. Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. Arch Intern Med 158 (1998) 1340-1345
9. Wright R.S., Reeder G.S., Herzog C.A., et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137 (2002) 563-570
10. Collet J.P., Montalescot G., Agnelli G., et al. Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events. Eur Heart J 26 (2005) 2285-2293
11. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
12. Gibson C.M., Dumain R.L., Gelfand E.V., et al. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome: observations in 13,307 patients in five TIMI trials. Eur Heart J 25 (2004) 1998-2005
13. Gibson C.M., Pinto D.S., Murphy S.A., et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 42 (2003) 1535-1543
14. Antman E.M., Morrow D.A., McCabe C.H., et al., ExTRACT-TIMI 25 Investigators. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 354 (2006) 1477-1488
15. Antman E.M., Morrow D.A., McCabe C.H., et al. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25). Am Heart J 149 (2005) 217-226
16. Sabatine M.S., Cannon C.P., Gibson C.M., et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352; (2005) 1179-1189
17. Chen Z.M., Jiang L.X., Chen Y.P., et al., COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366; (2005) 1607-1621
18. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 44 (2004) e1-e211
19. Van de Werf F., Ardissino D., Betriu A., et al., The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 24 (2003) 28-66
20. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
21. Levey A.S., Bosch J.P., Lewis J.B., et al., Modification of diet in renal disease study group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
22. Morrrow D.A., Antman E.M., Charlesworth A., et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, beside, clinical score for risk assessment at presentation. An Intravenous NPA for Treatment of Infarcting Myocardium Early II trial substudy. Circulation 102 (2000) 2031-2037
23. Collet J.P., Montalescot G., Choussat R., et al. Enoxaparin in unstable angina patients with renal failure. Int J Cardiol 80 (2001) 81-82
24. Eikelboom J.W., Quinlan D.J., Mehta S.R., et al. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials. Circulation 112 (2005) 3855-3867
25. Eagle K.A., Lim M.J., Dabbous O.H., et al., GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month post-discharge death in an international registry. JAMA 291 (2004) 2727-2733
26. The ASSENT-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 358 (2001) 605-613